Investigation Overview
Nov. 8, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA) shares was announced concerning whether the offer by Sun Pharmaceutical Industries Limited to acquire DUSA Pharmaceuticals, Inc. for $8.00 per NASDAQ:DUSA share and the takeover process are unfair to investors in NASDAQ:DUSA shares. The investigation by a law ...
You must register (for free) or login to view the entire investigation.